Caspofungin is an antifungal drug, the first of a new class termed the echinocandins from Merck & Co., Inc. It shows activity against infections with Aspergillus and Candida, and works by inhibiting ?(1,3)-D-Glucan of the fungal cell wall. Caspofungin is administered intravenously.